Open an account

ASP Isotopes

ASPI · NASDAQ

$2.03−$0.025 (−1.22%)TodayMarket closed ·
Prev close $2.05

About ASPI

ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. The company is headquartered in Dallas, Texas and currently employs 271 full-time employees. The company went IPO on 2022-11-10. Its proprietary technologies, the Aerodynamic Separation Process and Quantum Enrichment technology, are designed to enable the production of isotopes used in several industries. Its initial focus is on the production and commercialization of enriched Carbon-14 (C-14), Silicon-28 (Si-28) and Ytterbium-176 (Yb-176). The company is also a provider of liquid helium with operations at the Virginia Gas Project in South Africa. Its nuclear fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its specialist isotopes and related services segment is focused on research and development of technologies and methods used to separate isotopes for highly specialized target end markets.

Employees
271
Headquarters
Dallas, Texas
Listed
Nov 10, 2022
Sector
Materials
Industry
Chemicals
Website
aspisotopes.com

ASPI key statistics

Market cap
311.22M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
4.71M
Volume
4.07M
Open price
$2.00
High today
$2.18
Low today
$1.97
52 Week high
$11.22
52 Week low
$1.89

ASP Isotopes (ASPI) at a glance

ASP Isotopes (ASPI) last traded at $2.03, with a market cap of 311.22M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $1.97 and $2.18. The current price is 3.0% above the day's low and 6.9% below its high.

Volume so far is 4.07M shares, in line with the average of 4.71M shares a day.

Over the past year ASP Isotopes has ranged from $1.89 to $11.22, and now sits 2% of the way up that range.

ASP Isotopes met or beat analyst EPS estimates in 2 of the last 8 quarters. In Q2 FY26 it reported -$0.27 per share against an estimate of -$0.3128.

The average analyst price target is $13.26, 553.2% above the current price, from 2 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 2 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 5 analystsAvg $13.26
Low
$11.11
Now
$2.03
High
$15.75

ASPI earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 2 of the last 8 quarters, by 49.1% on average.

  1. Q3 FY24: reported -$0.12 per share against an estimate of -$0.0918
  2. Q4 FY24: reported -$0.13 per share against an estimate of -$0.0918
  3. Q1 FY25: reported -$0.12 per share against an estimate of -$0.102
  4. Q2 FY25: reported -$1.03 per share against an estimate of -$0.1122
  5. Q3 FY25: reported -$0.14 per share against an estimate of -$0.102
  6. Q4 FY25: reported -$0.75 per share against an estimate of -$0.1292
  7. Q1 FY26: reported -$0.06 per share against an estimate of -$0.3876
  8. Q2 FY26: reported -$0.27 per share against an estimate of -$0.3128

ASPI news

  • Press releasePRNewswire

    Did ASP Isotopes Inc. Insiders Breach their Fiduciary Duties to Shareholders?

  • Press releaseGlobe Newswire

    ASP Isotopes Hosts Inaugural Capital Markets Day and Provides Operational Update

  • Press releaseBusiness Wire

    ENDRA Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update

  • Press releaseGlobe Newswire

    ASP Isotopes Issues Letter to Shareholders

  • Press releaseGlobe Newswire

    ASP Isotopes to Hold Capital Markets Day on September 8

  • Press releaseBusiness Wire

    ASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement Financing

  • Dylan Berman

    ASP Isotopes Stock Surges After Silicon-28 Facility Restart

  • Dylan Berman

    ASP Isotopes Announces HALEU Supply MOU Through Subsidiary, Shares Move Higher

Similar companies

Companies in the same industry as ASP Isotopes

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.